Neuroimaging and neurologic findings in COVID-19

Takeaway

  • More than half of COVID-19 patients with neurologic manifestations had concurrent brain imaging abnormalities such as ischemic stroke, leptomeningeal enhancement (LME) and encephalitis.

Why this matters

  • Recent studies have highlighted the occurrence of neurologic manifestations associated with COVID-19, but their nature and frequency are extremely variable.

  • Greater awareness of neurologic manifestations and their underlying brain abnormalities in COVID-19 could inform treatment and improve patient outcomes.